These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 18623126)

  • 1. CHFR expression is preferentially impaired in smoking-related squamous cell carcinoma of the lung, and the diminished expression significantly harms outcomes.
    Takeshita M; Koga T; Takayama K; Kouso H; Nishimura-Ikeda Y; Yoshino I; Maehara Y; Nakanishi Y; Sueishi K
    Int J Cancer; 2008 Oct; 123(7):1623-30. PubMed ID: 18623126
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CHFR hypermethylation and EGFR mutation are mutually exclusive and exhibit contrastive clinical backgrounds and outcomes in non-small cell lung cancer.
    Koga T; Takeshita M; Yano T; Maehara Y; Sueishi K
    Int J Cancer; 2011 Mar; 128(5):1009-17. PubMed ID: 20473935
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Aberrant promoter hypermethylation of the CHFR gene in oral squamous cell carcinomas.
    Baba S; Hara A; Kato K; Long NK; Hatano Y; Kimura M; Okano Y; Yamada Y; Shibata T
    Oncol Rep; 2009 Nov; 22(5):1173-9. PubMed ID: 19787237
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Study of mRNA expression level and hypermethylation of CHFR promoter in the laryngeal squamous cell carcinoma tissue].
    He L; Ji W; Yang J; Zhao X
    Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2010 Aug; 24(15):673-7. PubMed ID: 20942233
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Alternative efficacy-predicting markers for paclitaxel instead of CHFR in non-small-cell lung cancer.
    Takeshita M; Koga T; Takayama K; Yano T; Maehara Y; Nakanishi Y; Sueishi K
    Cancer Biol Ther; 2010 Nov; 10(9):933-41. PubMed ID: 20855974
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Aberrant methylation of the CHFR gene in advanced hepatocellular carcinoma.
    Sakai M; Hibi K; Kanazumi N; Nomoto S; Inoue S; Takeda S; Nakao A
    Hepatogastroenterology; 2005; 52(66):1854-7. PubMed ID: 16334792
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Epigenetic inactivation of the CHFR gene in cervical cancer contributes to sensitivity to taxanes.
    Banno K; Yanokura M; Kawaguchi M; Kuwabara Y; Akiyoshi J; Kobayashi Y; Iwata T; Hirasawa A; Fujii T; Susumu N; Tsukazaki K; Aoki D
    Int J Oncol; 2007 Oct; 31(4):713-20. PubMed ID: 17786301
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Aberrant hypermethylation of the CHFR prophase checkpoint gene in human lung cancers.
    Mizuno K; Osada H; Konishi H; Tatematsu Y; Yatabe Y; Mitsudomi T; Fujii Y; Takahashi T
    Oncogene; 2002 Apr; 21(15):2328-33. PubMed ID: 11948416
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Promoter hypermethylation and silencing of CHFR mitotic stress checkpoint gene in human gastric cancers.
    Kang HC; Kim IJ; Park JH; Shin Y; Park HW; Ku JL; Yang HK; Lee KU; Choe KJ; Park JG
    Oncol Rep; 2004 Jul; 12(1):129-33. PubMed ID: 15201973
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CHFR aberrant methylation involves a subset of human lung adenocarcinoma associated with poor clinical outcomes.
    Koga T; Takeshita M; Ijichi K; Yano T; Maehara Y; Sueishi K
    Hum Pathol; 2013 Jul; 44(7):1382-90. PubMed ID: 23415374
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Aurora-B overexpression is correlated with aneuploidy and poor prognosis in non-small cell lung cancer.
    Takeshita M; Koga T; Takayama K; Ijichi K; Yano T; Maehara Y; Nakanishi Y; Sueishi K
    Lung Cancer; 2013 Apr; 80(1):85-90. PubMed ID: 23313006
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Aberrant methylation of the CHFR gene is frequently detected in non-invasive colorectal cancer.
    Morioka Y; Hibi K; Sakai M; Koike M; Fujiwara M; Kodera Y; Ito K; Nakao A
    Anticancer Res; 2006; 26(6B):4267-70. PubMed ID: 17201143
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hypermethylation of the TSLC1/IGSF4 promoter is associated with tobacco smoking and a poor prognosis in primary nonsmall cell lung carcinoma.
    Kikuchi S; Yamada D; Fukami T; Maruyama T; Ito A; Asamura H; Matsuno Y; Onizuka M; Murakami Y
    Cancer; 2006 Apr; 106(8):1751-8. PubMed ID: 16534787
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Aberrant p16 promoter methylation in smokers and former smokers with nonsmall cell lung cancer.
    Jarmalaite S; Kannio A; Anttila S; Lazutka JR; Husgafvel-Pursiainen K
    Int J Cancer; 2003 Oct; 106(6):913-8. PubMed ID: 12918069
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Epigenetic inactivation of CHFR in nasopharyngeal carcinoma through promoter methylation.
    Cheung HW; Ching YP; Nicholls JM; Ling MT; Wong YC; Hui N; Cheung A; Tsao SW; Wang Q; Yeun PW; Lo KW; Jin DY; Wang X
    Mol Carcinog; 2005 Aug; 43(4):237-45. PubMed ID: 15937956
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Aberrant expression of the CHFR prophase checkpoint gene in human B-cell non-Hodgkin lymphoma.
    Song A; Ye J; Zhang K; Yu H; Gao Y; Wang H; Sun L; Xing X; Yang K; Zhao M
    Leuk Res; 2015 May; 39(5):536-43. PubMed ID: 25798877
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Aberrant methylation of the FHIT gene in chronic smokers with early stage squamous cell carcinoma of the lung.
    Kim JS; Kim H; Shim YM; Han J; Park J; Kim DH
    Carcinogenesis; 2004 Nov; 25(11):2165-71. PubMed ID: 15231689
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Aberrant hypermethylation of the promoter region of the CHFR gene is rare in primary breast cancer.
    Tokunaga E; Oki E; Nishida K; Koga T; Yoshida R; Ikeda K; Kojima A; Egashira A; Morita M; Kakeji Y; Maehara Y
    Breast Cancer Res Treat; 2006 May; 97(2):199-203. PubMed ID: 16502017
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CHFR protein expression predicts outcomes to taxane-based first line therapy in metastatic NSCLC.
    Pillai RN; Brodie SA; Sica GL; Shaojin Y; Li G; Nickleach DC; Yuan L; Varma VA; Bonta D; Herman JG; Brock MV; Ribeiro MJ; Ramalingam SS; Owonikoko TK; Khuri FR; Brandes JC
    Clin Cancer Res; 2013 Mar; 19(6):1603-11. PubMed ID: 23386692
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chfr is required for tumor suppression and Aurora A regulation.
    Yu X; Minter-Dykhouse K; Malureanu L; Zhao WM; Zhang D; Merkle CJ; Ward IM; Saya H; Fang G; van Deursen J; Chen J
    Nat Genet; 2005 Apr; 37(4):401-6. PubMed ID: 15793587
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.